Furthermore, the expression of C3aR has been shown to increase after cerebral ischemia (Barnum et al., 2002) and its pharmacological inhibition with a C3aR antagonist conferred protection of anatomical damage associated with reduced endothelial ICAM-1 staining (Ducruet et al., 2008). This evidence concerns the gene C3AR1 and brain ischemia.